InterCure Ltd. (NASDAQ:INCR) Sees Significant Growth in Short Interest

InterCure Ltd. (NASDAQ:INCR) was the recipient of a large growth in short interest in November. As of November 30th, there was short interest totalling 37,200 shares, a growth of 129.6% from the November 15th total of 16,200 shares. Based on an average trading volume of 32,400 shares, the short-interest ratio is presently 1.1 days. Currently, 0.1% of the shares of the stock are short sold.

InterCure Price Performance

INCR opened at $1.32 on Friday. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.78 and a quick ratio of 1.15. InterCure has a 52-week low of $1.17 and a 52-week high of $3.72. The business’s fifty day moving average is $1.55 and its 200-day moving average is $1.96.

Institutional Investors Weigh In On InterCure

A number of large investors have recently bought and sold shares of the company. Virtu Financial LLC bought a new stake in shares of InterCure during the 3rd quarter worth approximately $43,000. Jane Street Group LLC acquired a new position in InterCure during the third quarter valued at approximately $49,000. Renaissance Technologies LLC lifted its stake in InterCure by 30.9% during the second quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock worth $91,000 after purchasing an additional 10,700 shares during the last quarter. Finally, AdvisorShares Investments LLC acquired a new stake in shares of InterCure in the 2nd quarter valued at $218,000. 8.34% of the stock is currently owned by institutional investors and hedge funds.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.